Open Menu Close Menu
CFO
  • News
  • Resources
  • Webinars
  • CFO Magazine
  • Newsletter
Search

Danaher

Was GE’s New CFO a Risky Choice?

Carolina Dybeck Happe's background makes her an unusual choice to run finance at the struggling conglomerate, a research report suggests.

GE Stock Surges on News of Biopharma Sale

The $21 billion sale to Danaher is a "pivotal milestone" in GE's plan to reduce debt and strengthen its balance sheet, CEO Larry Culp says.

Why You Should Bring Customers to the M&A Table

Deal-makers often don’t consider customers, according to a global branding consultancy. When they do, everybody wins.

CFO Follow us on social media
LinkedIn Facebook Twitter YouTube

Topics

  • Accounting & Tax
  • Credit & Capital
  • Risk & Compliance
  • Strategy
  • Technology
  • Human Capital

Content

  • Homepage
  • News
  • Resources
  • Webinars
  • CFO Magazine

About CFO

  • About CFO
  • Privacy Policy
  • Editorial Staff
  • Press
  • Advertise
  • Contact Us

Stay Updated

Sign up to receive the CFO newsletter.

Copyright © 2021 CFO. Industry Dive, Inc. (c) 2021, All rights reserved, 1255 23rd Street, NW, Suite 550, Washington, DC 20037

We use cookies to optimize your experience on our website and for analytics and advertising purposes. By continuing to use our site, you agree to our cookie policy. Learn more